Skip to the page

Data / Drug companies / Minocycline hydrochloride

Minocycline hydrochloride: 29 companies and 127 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Minocycline hydrochloride is listed in the FDA National Drug Code Directory by 29 companies, with 127 products in commercial distribution. 125 of the products (98.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; tablet, film coated, extended release; tablet, extended release, and the newest product started marketing on February 3, 2026.

The request: Get every company that lists minocycline hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
29
Products
127
Generic (ANDA) products
125 (98.4%)
Application numbers
17
Routes
Oral, Intravenous
Brand names
Minocin, Arestin
openFDA record search
api.fda.gov

Companies that list minocycline hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Aurobindo Pharma Limited11tablet, film coated, extended release; capsuleGeneric drugs (ANDA)August 21, 2019
Bryant Ranch Prepack11tablet, film coated, extended release; capsuleGeneric drugs (ANDA)December 23, 2019
Zydus Lifesciences Limited11tablet, extended release; capsuleGeneric drugs (ANDA)June 12, 2025
Zydus Pharmaceuticals USA Inc.11tablet, extended release; capsuleGeneric drugs (ANDA)June 12, 2025
Bryant Ranch Prepack10capsule; tablet, film coated, extended releaseGeneric drugs (ANDA)September 30, 2016
Bryant Ranch Prepack9tablet, film coated, extended release; capsuleGeneric drugs (ANDA)December 23, 2019
Ascend Laboratories, LLC8tablet, film coated, extended releaseGeneric drugs (ANDA)December 23, 2019
PD-Rx Pharmaceuticals, Inc.8tablet, film coated, extended releaseGeneric drugs (ANDA)December 23, 2019
Torrent Pharmaceuticals Limited6tablet; capsuleGeneric drugs (ANDA)April 2, 2015
A-S Medication Solutions4capsuleGeneric drugs (ANDA)April 2, 2015
Lupin Pharmaceuticals, Inc.4tablet, extended releaseGeneric drugs (ANDA)February 22, 2019
Aurobindo Pharma Limited3tablet, film coatedGeneric drugs (ANDA)May 1, 2020
Chartwell RX, LLC3tabletGeneric drugs (ANDA)December 26, 2007
NuCare Pharmaceuticals,Inc.3capsuleGeneric drugs (ANDA)April 2, 2015
Proficient Rx LP3capsuleGeneric drugs (ANDA)April 2, 2015
Proficient Rx LP3capsuleGeneric drugs (ANDA)May 13, 2013
Strides Pharma Science Limited3tabletGeneric drugs (ANDA)April 11, 2022
Advanced Rx of Tennessee, LLC2capsuleGeneric drugs (ANDA)May 23, 2024
Northwind Health Company, LLC2capsuleGeneric drugs (ANDA)January 24, 2023
PD-Rx Pharmaceuticals, Inc.2capsuleGeneric drugs (ANDA)May 1, 1993
Remedyrepack Inc.2capsuleGeneric drugs (ANDA)February 3, 2026
Actavis Pharma, Inc.1capsuleGeneric drugs (ANDA)May 1, 1993
American Health Packaging1capsuleGeneric drugs (ANDA)February 1, 2018
Major Pharmaceuticals1capsuleGeneric drugs (ANDA)April 2, 2015
Melinta Therapeutics, LLC1injectionNew drug applications (NDA)April 19, 2013
Northwind Health Company, LLC1capsuleGeneric drugs (ANDA)October 4, 2023
OraPharma, Inc.1powderNew drug applications (NDA)March 21, 2011
PD-Rx Pharmaceuticals, Inc.1capsuleGeneric drugs (ANDA)April 2, 2015
Preferred Pharmaceuticals Inc.1capsuleGeneric drugs (ANDA)November 6, 2017

Dosage forms

Dosage formProductsShare
Capsule4837.8%
Tablet, film coated, extended release4434.6%
Tablet, extended release2015.7%
Tablet107.9%
Tablet, film coated32.4%
Injection10.8%
Powder10.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)12598.4%
New drug applications (NDA)21.6%

Pharmacologic classes

ClassProducts
Tetracycline-class Drug127

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.